Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on Botulinum Toxin.

Carruthers1

  • 1Division of Dermatology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Skin Therapy Letter
|February 7, 2001
PubMed
Summary
This summary is machine-generated.

Botulinum toxin type-A (BTX-A) offers cosmetic benefits for wrinkles and hyperhidrosis. New formulations and type B may overcome antibody resistance, improving treatment efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wavelet correlations in the p model.

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·1995
Same author

Integral correlation measures for multiparticle physics.

Physical review. D, Particles and fields·1993
Same author

Power spectrum of hadronic multiparticle rapidity distributions.

Physical review. D, Particles and fields·1992
Same author

Correlations and intermittency in high-energy nuclear collisions.

Physical review. C, Nuclear physics·1991
Same author

Correlation functions and factorial correlator data.

Physical review. D, Particles and fields·1991
Same author

Structure of correlation functions.

Physical review. A, Atomic, molecular, and optical physics·1991
Same journal

Exosomes in Dermatology.

Skin therapy letter·2026
Same journal

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

Skin therapy letter·2026
Same journal

Erratum to: Deuruxolitinib for Alopecia Areata.

Skin therapy letter·2026
Same journal

Advances in the Management of Hyperhidrosis.

Skin therapy letter·2026
Same journal

Topical Ruxolitinib for the Treatment of Hidradenitis Suppurativa.

Skin therapy letter·2026
Same journal

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis.

Skin therapy letter·2026
See all related articles

Area of Science:

  • Neurology
  • Dermatology
  • Pharmacology

Background:

  • Botulinum toxin type-A (BTX-A) is a neurotoxin that inhibits acetylcholine release, causing temporary muscle paralysis.
  • Approved indications include cervical dystonia, cerebral palsy, strabismus, blepharospasm, and hemifacial spasm.
  • Unlabeled cosmetic uses for wrinkles and hyperhidrosis are of significant dermatological interest.

Purpose of the Study:

  • To review the applications and limitations of botulinum toxin type-A (BTX-A).
  • To discuss antibody formation and potential solutions for treatment resistance.

Main Methods:

  • Literature review of BTX-A applications, mechanism of action, and antibody development.
  • Analysis of new BTX-A formulations and alternative botulinum toxin types.

Related Experiment Videos

Main Results:

  • BTX-A is effective for neurological and cosmetic conditions.
  • Antibody development can render BTX-A treatment ineffective in a small percentage of patients.
  • Newer BTX-A formulations and botulinum toxin type B show promise in overcoming antibody resistance.

Conclusions:

  • BTX-A remains a valuable therapeutic agent with expanding applications.
  • Ongoing research addresses limitations such as antibody formation, enhancing treatment longevity.